EUVIMEDEUVIMED entdecken
Crossref

Endothelial factors and blood homocysteine level in adolescents with rheumatic diseases

T. O. Holovko, L. F. Bohmat, N. S. Shevchenko, Yu. V. Volkova, L. L. Sukhova, O. S. Pavlova

Modern medical technology · 2024

DOI: 10.14739/mmt.2024.1.298488 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern medical technology, 2024. Verfasst von T. O. Holovko und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is known that the dysfunction of the endothelium has crucial role in many pathological conditions and underlines adverse cardiovascular events. The aim of our study was to determine biologically active substances in the blood that affect endothelial function and homocysteine level in adolescents with rheumatic diseases. Materials and methods. We examined 68 patients with rheumatic diseases, among them 25 patients with systemic lupus erythematosus (SLE) and 43 patients with juvenile idiopathic arthritis (JIA). Obtained results were compared with similar indicators of peers from the control group. All patients received basic therapy for 12 or more months at the time of examination. Biologically active substances (Homocysteine (Hcy), vascular endothelial growth factor (VEGF), high-sensitivity C-reactive protein (hs-CRP)) were studied by enzyme-linked immunosorbent assay, brain natriuretic peptide (NT-proBNP) by competitive immunoassay, and angiotensin-converting enzyme (ACE) by turbidimetric FAPGG kinetics method.

Results

Patients with rheumatic diseases had a significantly higher level of BNP (p < 0.01). These changes were most significant in patients with SLE. The level of Hcy did not differ from the similar indicator of the control group, but in patients with SLE it was significantly higher (p < 0.01) than in patients with JIA.

Conclusions

In patients with rheumatic diseases, biologically active substances level affecting the endothelium function depends on the disease. Biologically active substances affecting the function of the endothelium were within normal values. Thus, in children with SLE compared with JIA children, an increase in Hcy and NT-proBNP, and a decrease in ACE and hs-CRP protein were found. In children with JIA, normal levels of Hcy and ACE are accompanied by an increase in NT-proBNP and hs-CRP. In adolescents aged 10–18 years with SLE and JIA, multidirectional changes in biologically active substances and homocysteine, affecting the endothelial function of blood vessels were found.

Zitieren

APA

Holovko, T. O., Bohmat, L. F., Shevchenko, N. S., Volkova, Y. V., Sukhova, L. L., & Pavlova, O. S. (2024). Endothelial factors and blood homocysteine level in adolescents with rheumatic diseases. Modern medical technology. https://doi.org/10.14739/mmt.2024.1.298488

Vancouver

Holovko TO, Bohmat LF, Shevchenko NS, Volkova YV, Sukhova LL, Pavlova OS. Endothelial factors and blood homocysteine level in adolescents with rheumatic diseases. Modern medical technology. 2024. doi:10.14739/mmt.2024.1.298488

BibTeX
@article{Holovko2024,
  author = {Holovko, T. O. and Bohmat, L. F. and Shevchenko, N. S. and Volkova, Yu. V. and Sukhova, L. L. and Pavlova, O. S.},
  title = {Endothelial factors and blood homocysteine level in adolescents with rheumatic diseases},
  journal = {Modern medical technology},
  year = {2024},
  doi = {10.14739/mmt.2024.1.298488}
}
Kostenlos starten →